Authors:
Everse, LA
Anderson, LD
van Rooijen, N
Mullen, CA
Citation: La. Everse et al., Bone marrow transplant conditioning intensified with liposomal clodronate to eliminate residual host antigen presenting cells fails to ameliorate GVHD and increases peri-BMT mortality, TRANSPLANT, 71(5), 2001, pp. 611-618
Authors:
Quintanilla-Vega, B
Hoover, DJ
Bal, W
Silbergeld, EK
Waalkes, MP
Anderson, LD
Citation: B. Quintanilla-vega et al., Lead interaction with human protamine (HP2) as a mechanism of male reproductive toxicity, CHEM RES T, 13(7), 2000, pp. 594-600
Citation: Ld. Anderson et Ml. Delaney, Sequential extraction and analysis of phosphorus in marine sediments: Streamlining of the SEDEX procedure, LIMN OCEAN, 45(2), 2000, pp. 509-515
Authors:
Anderson, LD
Mori, S
Mann, S
Savary, CA
Mullen, CA
Citation: Ld. Anderson et al., Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease, CANCER RES, 60(20), 2000, pp. 5797-5802
Citation: Ld. Anderson et al., Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease, BLOOD, 95(7), 2000, pp. 2426-2433
Authors:
Anderson, LD
Hudson, JM
Savary, CA
Fisk, B
Gershenson, DM
Ioannides, CG
Citation: Ld. Anderson et al., HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells, CANCER IMMU, 48(7), 1999, pp. 401-410
Authors:
Anderson, LD
Petropoulos, D
Everse, LA
Mullen, CA
Citation: Ld. Anderson et al., Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine, CANCER RES, 59(7), 1999, pp. 1525-1530